SPAC19D5.10c Antibody

What is the SPAC19D5.10c gene and its protein product in S. pombe?

SPAC19D5.10c appears to be related to the Sup11p protein in Schizosaccharomyces pombe, which shows significant homology to Saccharomyces cerevisiae Kre9. Sup11p is an essential protein involved in β-1,6-glucan formation in the cell wall and is indispensable for proper septum assembly in fission yeast . The protein contains specific domains that facilitate its function in cell wall synthesis and maintenance. When investigating SPAC19D5.10c antibodies, understanding this fundamental relationship provides context for experimental design and interpretation of results.

How are antibodies against yeast proteins like SPAC19D5.10c typically generated?

Antibodies against yeast proteins like SPAC19D5.10c are commonly produced through several methodological approaches. Researchers typically collect peripheral blood samples from host organisms and isolate B cells for antibody production. For instance, one effective approach involves sorting antigen-binding memory B cells and antigen-nonspecific plasma cells, then amplifying the sequences of heavy-chain and light-chain variable regions by PCR for insertion into expression vectors . Studies have demonstrated that neutralizing antibodies can be produced more efficiently from memory B cells than from plasma cells . For S. pombe proteins, researchers often generate antibodies against GST-fusion peptides of the target protein, followed by affinity purification of the polyclonal antibodies, as demonstrated in protocols for Sup11p antibody production .

What screening methods are most effective for validating antibodies against S. pombe proteins?

Effective screening of antibodies against S. pombe proteins involves multiple complementary assays. Initial screening often employs cell-based inhibition assays that examine the binding specificity of the antibody to the target protein. For membrane or cell wall proteins like those related to SPAC19D5.10c/Sup11p, researchers can utilize techniques such as Western blotting following spheroblasting of S. pombe cells and proteinase K protection assays to verify specificity . Confirmation of binding can be achieved through cell fusion assays, which have been shown to correlate well with initial inhibition screening results . For definitive validation, end-point micro-neutralization assays determine the minimum concentration required for complete binding, with correlation between micro-neutralization titers and binding rates providing robust confirmation of antibody specificity and activity .

How do mutations in the SPAC19D5.10c gene affect antibody epitope recognition?

Mutations in genes like SPAC19D5.10c can significantly alter epitope recognition by antibodies. Research on antibody binding has demonstrated that point mutations at specific amino acid positions can dramatically affect neutralizing ability of antibodies. For example, in studies of spike protein antibodies, mutations at positions like E484K affected binding of 8 out of 11 top antibodies, while mutations at W406, K417, F456, T478, F486, F490, and Q493 affected 3-4 of 11 antibodies . For SPAC19D5.10c/Sup11p, which is involved in cell wall formation, mutations would likely alter protein structure and post-translational modifications, particularly in S/T-rich regions that are typically highly O-mannosylated in wild-type yeast . These modifications can mask potential epitopes, as demonstrated by the observation that hypo-mannosylated Sup11p can be N-glycosylated on an unusual N-X-A sequon that is normally masked by O-mannosylation . Researchers should consider these modification patterns when designing antibodies against specific epitopes.

What computational approaches can optimize antibody design against S. pombe proteins?

Computational protocols for antibody design against S. pombe proteins can significantly enhance experimental success. A systematic approach involves multiple stages: First, RosettaAntibody can be employed to solve the problem of absent 3D structures, generating structural models of the antibody . This is followed by RosettaRelax to minimize energy and approximate the bound state configuration . For proteins like SPAC19D5.10c/Sup11p with complex structural features, a two-step docking approach is recommended, comprising global and local docking to establish binding conformations . After identifying potential binding conformations, alanine scanning provides critical information about hotspots (key residues) on the antibody interface . Finally, computational affinity maturation can improve properties of the existing antibody design, optimizing both affinity and stability compared to the original . This systematic computational pipeline addresses the challenges inherent in designing antibodies against complex yeast proteins with extensive post-translational modifications.

How does protein glycosylation of SPAC19D5.10c/Sup11p affect antibody recognition?

Protein glycosylation of SPAC19D5.10c/Sup11p significantly impacts antibody recognition through several mechanisms. Research has demonstrated that Sup11p undergoes extensive O-mannosylation in wild-type cells, and this glycosylation pattern is altered in O-mannosylation mutant backgrounds, resulting in hypo-mannosylated forms of the protein . Importantly, when expressed in an O-mannosylation mutant background, Sup11p can be N-glycosylated on an unusual N-X-A sequon that is normally masked by O-mannosylation in S/T-rich regions . This competition between different glycosylation types directly affects epitope accessibility and recognition. When designing antibodies against such proteins, researchers should consider targeting regions less likely to undergo variable glycosylation or develop multiple antibodies targeting different epitopes to ensure detection under various glycosylation states. Additionally, treatment with deglycosylation enzymes like EndoH can be employed in experimental protocols to remove N-linked glycans and improve consistent antibody recognition .

What are the optimal conditions for immunoprecipitation using SPAC19D5.10c antibodies?

Optimal immunoprecipitation with SPAC19D5.10c antibodies requires specific conditions that account for the protein's cellular localization and characteristics. Since proteins like Sup11p are involved in cell wall synthesis and likely localize to secretory pathway compartments from the endoplasmic reticulum to the plasma membrane (similar to Kre-family proteins in S. cerevisiae) , cell lysis must be performed under conditions that maintain protein structure while effectively solubilizing membrane components. Based on protocols for similar yeast cell wall proteins, spheroblasting S. pombe cells with zymolyase before gentle lysis in a buffer containing 1% Triton X-100 or similar non-ionic detergent is recommended . For immunoprecipitation, antibodies should be conjugated to protein A/G beads or magnetic beads at a concentration of 5-10 μg antibody per reaction. Pre-clearing lysates with unconjugated beads for 1 hour at 4°C can reduce non-specific binding. Washing steps should include buffers with decreasing salt concentrations to maintain specific interactions while removing contaminants. Final elution can be performed using a gentle elution buffer (pH 2.8) followed by immediate neutralization to preserve protein structure for downstream applications.

How can researchers effectively perform Western blotting for SPAC19D5.10c detection?

Effective Western blotting for SPAC19D5.10c detection requires optimization at multiple steps of the procedure. Based on protocols used for similar S. pombe proteins, researchers should first prepare samples by spheroblasting cells to remove the cell wall, which improves protein extraction efficiency . Cell lysis should be performed in a buffer containing protease inhibitors to prevent degradation of the target protein. For membrane-associated proteins like those involved in cell wall synthesis, inclusion of 1-2% SDS in the sample buffer enhances solubilization. Proteins should be separated on an 8-12% SDS-PAGE gel, with a longer run time (2-3 hours at 100V) to achieve better separation.

After transfer to a PVDF membrane (recommended over nitrocellulose for glycoproteins), blocking should be performed with 5% non-fat milk in TBST for 1 hour at room temperature. Primary antibody incubation should be conducted at a dilution of 1:1000-1:5000 overnight at 4°C. For heavily glycosylated proteins like Sup11p, treatment with EndoH before SDS-PAGE can improve detection by removing N-linked glycans that might interfere with antibody recognition . Additionally, for proteins with multiple glycoforms, PAS-Silver staining can be used as a complementary technique to Western blotting to visualize all glycoprotein variants .

What purification strategies yield the highest quality antibodies against S. pombe cell wall proteins?

Producing high-quality antibodies against S. pombe cell wall proteins requires specialized purification strategies. The most effective approach involves a multi-step process beginning with antigen preparation. For cell wall proteins like those related to SPAC19D5.10c/Sup11p, using GST-fusion peptides representing specific protein domains has proven successful . After immunization and antibody production, affinity purification using antigen-coupled columns significantly enhances specificity.

For polyclonal antibodies, research has demonstrated the effectiveness of a two-stage purification process: first passing serum through a GST column to remove anti-GST antibodies, followed by affinity purification on a column containing the GST-fusion peptide of the target protein . This removes cross-reactive antibodies while concentrating those specific to the target. For monoclonal antibody production, selecting B cells by antigen-specificity is crucial, as studies have shown that antibodies produced from antigen-specific memory B cells exhibit superior properties compared to those from antigen-nonspecific plasma cells . Quality control should include Western blotting against wild-type and knockout/knockdown strains to confirm specificity, as well as immunofluorescence microscopy to verify expected subcellular localization patterns.

How can researchers distinguish between specific and non-specific binding in immunofluorescence experiments with SPAC19D5.10c antibodies?

Distinguishing specific from non-specific binding in immunofluorescence experiments requires multiple validation controls. For SPAC19D5.10c antibodies, researchers should include:

• Genetic controls: Compare staining patterns between wild-type cells and cells with conditionally repressed gene expression (e.g., using nmt81-promoter regulated strains similar to the nmt81-sup11 system) . Specific staining should be significantly reduced in knockdown cells.

• Peptide competition: Pre-incubating the antibody with the antigenic peptide should abolish specific staining while leaving non-specific binding unaffected.

• Colocalization analysis: For proteins like SPAC19D5.10c/Sup11p involved in cell wall synthesis, colocalization with known secretory pathway markers (ER, Golgi, plasma membrane) provides validation of specificity . Quantitative colocalization metrics (Pearson's correlation coefficient >0.7) should be calculated.

• Signal-to-background ratio assessment: Specific binding typically yields a signal-to-background ratio >3:1. Lower ratios may indicate problems with antibody specificity or methodology.

• Cross-adsorption: When significant background exists, cross-adsorbing antibodies against fixed cells lacking the target protein can improve specificity.

By implementing these controls systematically, researchers can confidently distinguish between genuine SPAC19D5.10c localization and artifacts.

What transcriptomic changes occur in response to SPAC19D5.10c depletion and how do they impact experimental interpretation?

Transcriptomic changes following SPAC19D5.10c depletion create complex experimental contexts that must be considered when interpreting antibody-based studies. Research on Sup11p depletion in S. pombe revealed significant cell wall remodeling processes and altered expression of numerous glucanases and glucan-modifying enzymes . Microarray hybridization analysis of the nmt81-sup11 mutant identified substantial regulation of cell wall glucan-modifying enzymes, with Gas2p (a β-1,3-glucanosyl-transferase family member) playing a crucial role in the observed septum material depositions .

These transcriptomic changes have several implications for antibody-based experiments:

• Altered protein interactions: Changed expression of interacting partners may affect co-immunoprecipitation results.

• Modified cellular compartments: Depletion leads to malformation of the septum with massive accumulation of cell wall material , potentially altering antibody accessibility.

• Compensatory mechanism activation: Upregulation of related pathways may introduce confounding factors in phenotypic analyses.

• Post-translational modification changes: Cell wall stress response often alters glycosylation patterns, affecting epitope recognition .

Researchers should incorporate RNA-seq or qPCR validation of key differentially expressed genes alongside antibody-based experiments to properly contextualize findings and avoid misinterpretation of results affected by these transcriptomic changes.

How do cell cycle phase and growth conditions affect SPAC19D5.10c expression and antibody detection efficiency?

Cell cycle phase and growth conditions significantly influence SPAC19D5.10c expression and the efficiency of antibody detection in experimental settings. Since proteins like Sup11p are essential for septum formation, their expression and localization patterns vary throughout the cell cycle . Based on research with similar cell wall synthesis proteins in S. pombe, expression typically peaks during G1/S transition and remains elevated through septum formation phases.

The following factors must be considered when designing experiments:

Growth conditions also dramatically affect detection efficiency. Nutrient limitation stress alters cell wall composition and thickness, potentially masking epitopes. Temperature shifts (particularly above 36°C) induce heat shock responses that modify protein glycosylation patterns . Cell density affects expression levels, with mid-log phase cultures (OD600 0.5-0.8) typically showing optimal expression-to-background ratios for detection.

For consistent results, researchers should synchronize cultures using methods like lactose gradient centrifugation or nitrogen starvation release, and standardize growth conditions (including media composition, temperature, and harvest density) across experiments. Sample preparation should include optimization of cell wall digestion conditions, as over-digestion can release the target protein while under-digestion may prevent antibody access .